{"id":"https://openalex.org/W4308401736","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.1048","title":"1048 Interplay of IL-12 and IFNg to induce Treg fragility within the tumor microenvironment","display_name":"1048 Interplay of IL-12 and IFNg to induce Treg fragility within the tumor microenvironment","publication_year":2022,"publication_date":"2022-11-01","ids":{"openalex":"https://openalex.org/W4308401736","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.1048"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2022-sitc2022.1048","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.1048","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2022-sitc2022.1048","pdf_url":"https://jitc.bmj.com/content/jitc/10/Suppl_2/A1090.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/10/Suppl_2/A1090.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Ellen Scott","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ellen Scott","raw_affiliation_strings":["University of Pittsburgh, Pittsburgh, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh, Pittsburgh, PA, USA","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047331973","display_name":"Angela Marie Gocher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Angela Gocher","raw_affiliation_strings":["University of Pittsburgh, Pittsburgh, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh, Pittsburgh, PA, USA","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008106149","display_name":"Creg J. Workman","orcid":"https://orcid.org/0000-0002-9964-9509","observed_orcids":["https://orcid.org/0000-0002-9964-9509"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Creg Workman","raw_affiliation_strings":["University of Pittsburgh, Pittsburgh, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh, Pittsburgh, PA, USA","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5001000053","display_name":"Dario A.A. Vignali","orcid":"https://orcid.org/0000-0002-2771-5992","observed_orcids":["https://orcid.org/0000-0002-2771-5992"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dario Vignali","raw_affiliation_strings":["University of Pittsburgh, Pittsburgh, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh, Pittsburgh, PA, USA","institution_ids":["https://openalex.org/I170201317"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I170201317"],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A1090","last_page":"A1090"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.823199987411499,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.823199987411499,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.16769999265670776,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.9599999785423279},{"id":"https://openalex.org/keywords/il-12-signaling","display_name":"IL-12 signaling","score":0.859000027179718},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.7889999747276306},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.8399999737739563},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.7879999876022339},{"id":"https://openalex.org/keywords/foxp3","display_name":"Foxp3","score":0.9340000152587891},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.7360000014305115},{"id":"https://openalex.org/keywords/b16-melanoma","display_name":"B16 melanoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/tumor-growth","display_name":"tumor growth","score":0.41499999165534973},{"id":"https://openalex.org/keywords/treg-suppressive-function","display_name":"Treg suppressive function","score":0.6039999723434448},{"id":"https://openalex.org/keywords/conditional-knockout","display_name":"conditional knockout","score":0.3070000112056732}],"concepts":[{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.5598155856132507},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.5541523694992065},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.47985976934432983},{"id":"https://openalex.org/C2779727006","wikidata":"https://www.wikidata.org/wiki/Q426188","display_name":"FOXP3","level":3,"score":0.4736025333404541},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4618507921695709},{"id":"https://openalex.org/C79484868","wikidata":"https://www.wikidata.org/wiki/Q5971673","display_name":"IL-2 receptor","level":4,"score":0.4226151704788208},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3893939256668091},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.37376731634140015},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3415766954421997}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jitc-2022-sitc2022.1048","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.1048","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2022-sitc2022.1048","pdf_url":"https://jitc.bmj.com/content/jitc/10/Suppl_2/A1090.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2022-sitc2022.1048","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.1048","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2022-sitc2022.1048","pdf_url":"https://jitc.bmj.com/content/jitc/10/Suppl_2/A1090.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4308401736.pdf","grobid_xml":"https://content.openalex.org/works/W4308401736.grobid-xml"},"referenced_works_count":2,"referenced_works":["https://openalex.org/W2153389047","https://openalex.org/W3168968023"],"related_works":["https://openalex.org/W4404053223","https://openalex.org/W2802745401","https://openalex.org/W4313368686","https://openalex.org/W2049204344","https://openalex.org/W4306734484","https://openalex.org/W2569451357","https://openalex.org/W2285369305","https://openalex.org/W7097985289","https://openalex.org/W1606027964","https://openalex.org/W2127793792"],"abstract_inverted_index":{"Background":[0],"Immune":[1],"cells":[2,24,409],"play":[3],"an":[4,229],"integral":[5],"role":[6],"in":[7,121,217,251,323,336,365,449,464],"the":[8,13,18,27,91,102,128,157,182,223,309,321,332,345,370,373,394,450,465,479],"prevention":[9],"as":[10,12,85,99,101],"well":[11,100],"progression":[14],"of":[15,34,52,68,73,104,117,130,159,184,201,240,248,256,270,282,311,347,390,467,481],"cancers.":[16],"Within":[17],"T":[19,23,29,387,408],"cell":[20,30],"compartment,":[21],"regulatory":[22,407],"(Tregs)":[25],"suppress":[26],"anti-tumor":[28],"response":[31,80,137,374],"through":[32],"use":[33],"direct":[35],"and":[36,136,155,161,180,197,219,254,340,367,372,485],"indirect":[37],"mechanisms.1,2":[38],"However,":[39,87,259],"under":[40,471],"some":[41],"circumstances":[42],"Tregs":[43,122,265,292,366],"can":[44,361],"lose":[45],"their":[46,53],"suppressive":[47],"activity":[48],"while":[49],"retaining":[50],"expression":[51],"master":[54],"transcription":[55],"factor,":[56],"Foxp3,":[57],"a":[58,75,109,114,172,237],"phenomenon":[59],"our":[60,337],"lab":[61],"has":[62],"termed":[63],"Treg":[64,69,97,134,188,312,342,431],"fragility.3":[65],"A":[66],"hallmark":[67],"fragility":[70,98,297,364],"is":[71,89,211,305,326,350],"production":[72],"IFNg,":[74],"pleiotropic":[76],"cytokine":[77],"necessary":[78,307],"for":[79,308],"to":[81,96,126,138,213,296,375,433,478],"cancer":[82],"immunotherapies":[83,140],"such":[84],"anti-PD1.4":[86],"it":[88],"unknown":[90],"exact":[92],"mechanism":[93,346],"that":[94,208,290,303,320,325,359],"leads":[95],"consequences":[103],"Treg-produced":[105],"IFNg.":[106],"By":[107],"using":[108,228],"novel":[110],"transgenic":[111],"mouse":[112,338],"with":[113,149,171,176,244,262,268],"conditional":[115],"deletion":[116,175],"IL-12Rb2":[118],"(Il12rb2.Thy1.1L/LhNGFR":[119],"Foxp3Cre.YFP)":[120],"we":[123],"were":[124,266,462],"able":[125,212],"test":[127],"effect":[129,183],"IL-12":[131,160,220,230,241,304,333,349,360],"signaling":[132,334],"on":[133,187],"function":[135,189],"different":[139,165],"during":[141],"tumor":[142,195,273,395],"progression.":[143],"Methods":[144],"We":[145,167,205],"inoculated":[146,169],"wildtype":[147,257],"mice":[148,170,261,284,461],"MC-38":[150,177],"adenocarcinoma":[151],"or":[152,178,447],"B16":[153,179],"melanoma":[154],"determined":[156],"amount":[158,239],"IFNg":[162,218,249,324],"induced":[163,327],"by":[164,193,328],"immunotherapies.":[166],"also":[168],"Treg-specific":[173],"IL12R":[174],"characterized":[181],"IL-12R":[185,263],"loss":[186,335],"after":[190,285],"immunotherapy":[191,329],"treatment":[192,288],"measuring":[194],"growth":[196,274],"flow":[198,279],"cytometric":[199,280],"analyses":[200,281],"intratumoral":[202],"Tregs.":[203],"Results":[204],"have":[206],"found":[207],"anti-PD1":[209],"therapy":[210,232],"cause":[214],"modest":[215],"increases":[216,247],"levels":[221,250],"within":[222],"tumor.":[224],"In":[225],"contrast,":[226],"when":[227,260],"inducing":[231],"(anti-CD40":[233],"agonism)":[234],"there":[235],"was":[236,275],"larger":[238],"intratumorally":[242],"along":[243],"very":[245],"large":[246],"both":[252],"tumors":[253],"serum":[255],"mice.":[258],"deficient":[264],"treated":[267],"either":[269],"these":[271,283,291,316,352],"therapies,":[272],"not":[276,306],"affected.":[277],"Additionally,":[278],"anti-CD40":[286],"agonist":[287],"suggests":[289,358],"are":[293],"still":[294,354],"sensitive":[295],"induction.":[298],"Conclusions":[299],"These":[300],"data":[301,317],"suggest":[302],"induction":[310],"fragility.":[313,343],"More":[314],"specifically,":[315],"may":[318,330],"indicate":[319],"increase":[322],"circumvent":[331],"model":[339],"induce":[341,363],"While":[344],"how":[348],"effecting":[351],"changes":[353],"unknown,":[355],"this":[356],"evidence":[357],"indirectly":[362],"therefore":[368],"augment":[369],"TME":[371],"immunotherapy.":[376],"References":[377],"Scott":[378],"EN,":[379],"Gocher":[380,439],"AM,":[381,440],"Workman":[382,404,441],"CJ,":[383,442],"Vignali":[384,400,443],"DAA.":[385,444],"Regulatory":[386],"cells:":[388],"barriers":[389],"immune":[391],"infiltration":[392],"into":[393],"microenvironment.":[396],"Front":[397],"Immunol":[398,455],"2021;12:702726.":[399],"DAA,":[401],"Collison":[402],"LW,":[403],"CJ.":[405],"How":[406],"work.":[410],"Nat":[411,453],"Rev":[412,454],"Immunol.":[413],"2008;8(7):523\u201332.":[414],"Overacre-Delgoffe":[415],"AE,":[416],"Chikina":[417],"M,":[418],"Dadey":[419],"RE,":[420],"Yano":[421],"H,":[422],"Brunazzi":[423],"EA,":[424],"Shayan":[425],"G,":[426],"et":[427],"al.":[428],"Interferon-?":[429],"Drives":[430],"Fragility":[432],"Promote":[434],"Anti-tumor":[435],"Immunity.":[436],"Cell":[437],"2017;169(6):1130\u20131141.e11.":[438],"Interferon-?:":[445],"teammate":[446],"opponent":[448],"tumour":[451],"microenvironment?":[452],"2022":[456],"Mar;22(3):158\u201372.":[457],"Ethics":[458],"Approval":[459],"All":[460,474],"co-housed":[463],"University":[466,480],"Pittsburgh":[468,482],"Animal":[469,483],"Facility":[470],"SPF":[472],"conditions.":[473],"experiments":[475],"strictly":[476],"adhered":[477],"Care":[484],"Use":[486],"Committee":[487],"requirements.":[488]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2022-11-11T00:00:00"}